Optimizing Implementation in Cancer Control: OPTICC - Implementation Lab Core

优化癌症控制的实施：OPTICC - 实施实验室核心

• 批准号: 10022115
• 负责人: Margaret A Hannon
• 金额: $ 13.13万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-20 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10022115
• 关键词: Address; Alaska; Cancer Center; Cancer Control; Caring; Clinic; Clinical; Cohort Studies; Collaborations; Communities; Continuity of Patient Care; Data; Effectiveness; Ensure; Environment; Evidence based intervention; Foundations; Funding; Future; Goals; Hawaii; Idaho; Individual; Infrastructure; Inpatients; Investigation; Laboratories; Learning; Malignant Neoplasms; Measures; Methods; Monitor; Montana; Northwestern United States; Outcome; Outpatients; Phase; Pilot Projects; Population; Primary Health Care; Procedures; Process; Public Health; Research; Research Infrastructure; Research Personnel; Resources; Rural; Safety; Service setting; Shapes; Site; System; Testing; Underserved Population; Wages; Washington; Workplace; Wyoming; cancer care; cancer health disparity; clinical care; clinical research site; community setting; data sharing; experience; experimental study; health disparity; human subject; implementation science; improved; innovation; interest; peer learning; recruit; success; tool

IMPLEMENTATION LABORATORY CORE SUMMARY The Implementation Laboratory Core will establish and coordinate a network of diverse clinical and community sites that can conduct the OPTICC Center’s implementation science (IS) studies, implement cancer control evidence-based interventions (EBIs), and shape the Center’s research agenda. The Implementation Lab has recruited five research-ready Lab Partners that include diverse clinical sites across our 5-state Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region. The Lab Partners are all established networks experienced with collaborative multi-site research and/or quality improvement efforts. The Lab includes primary care and cancer care clinics, outpatient and inpatient settings, and rural and urban environments that provide care to traditionally underserved populations, permitting implementation studies that address health disparities. The Implementation Lab has four specific aims. Aim 1 is to establish administrative procedures to ensure effective, efficient coordination of the Implementation Lab and promote productive, mutually beneficial collaborations between Lab Partners and the OPTICC Center. Aim 2 is to support collaboration between Implementation Lab Partners and OPTICC Study Leads in multiple, concurrent innovative implementation studies, measures and methods studies, and pilot studies that address three stages of optimizing EBI implementation in cancer control. Aim 3 is to develop infrastructure and processes to support large-scale implementation studies that involve data sharing across Lab Partners and harmonized procedures for human subjects, data safety and monitoring. Aim 4 is to monitor Implementation Lab Partners’ ongoing cancer control EBI implementation initiatives; track progress, successes and challenges of Center-supported EBI implementation efforts; and identify emerging implementation priorities to inform the Center’s research agenda. Our Lab Partners’ on-the-ground implementation priorities, initiatives and challenges will drive OPTICC investigators’ implementation study aims and methods. The Implementation Lab’s expected outcomes include improved implementation of cancer control EBIs in clinical and community settings; a “learning laboratory” through which Lab Partners engage in peer learning and gain access to practice tools, guidance, and findings from the Center’s studies, and OPTICC investigators learn about real-world implementation initiatives and challenges that drive IS; and a research infrastructure that can participate in the larger, follow-on, multi-site, multi-level studies that will emanate from OPTICC and other Advanced and Developing Centers.

实施实验室核心总结 实施实验室核心将建立和协调不同临床和社区的网络 可以进行OPTICC中心的实施科学(IS)研究、实施癌症控制的站点 循证干预(EBI)，并塑造该中心的研究议程。实施实验室拥有 招募了五个随时准备进行研究的实验室合作伙伴，其中包括我们华盛顿州五个州的不同临床站点， 怀俄明州、阿拉斯加州、蒙大拿州和爱达荷州(WWAMI)地区。实验合作伙伴都是成熟的网络 具有多站点协作研究和/或质量改进方面的经验。本实验包括主要课程 护理和癌症护理诊所、门诊和住院环境以及农村和城市环境 向传统上服务不足的人群提供护理，从而能够开展解决健康差距问题的研究。 实施实验室有四个具体目标。目标1是建立行政程序，以确保 有效、高效地协调实施实验室，促进富有成效和互惠互利 实验室合作伙伴和OPTICC中心之间的合作。目标2是支持 实施实验室合作伙伴和OPTICC研究引领多个并行创新实施 针对优化EBI的三个阶段的研究、措施和方法研究以及试点研究 在癌症控制中的实施。目标3是开发基础设施和流程以支持大规模 涉及实验室合作伙伴之间的数据共享和人力资源协调程序的实施研究 主题、数据安全和监控。目标4是监测实施实验室合作伙伴正在进行的癌症控制 EBI实施计划；跟踪中心支持的EBI的进展、成功和挑战 执行工作；并确定新出现的执行优先事项，以便为中心的研究议程提供信息。 我们的实验室合作伙伴的现场实施优先事项、倡议和挑战将推动OPTICC 调查员实施研究的目的和方法。实施实验室的预期成果包括 在临床和社区环境中更好地实施癌症控制EBI；一个“学习实验室” 实验室合作伙伴参与同行学习并获得实践工具、指导和调查结果 从该中心的研究中，OPTICC调查人员了解了现实世界的实施倡议和 推动这一挑战的是；以及能够参与更大、后续、多站点、 将由OPTICC和其他先进和发展中的中心发起的多层次研究。